Prospect of lenvatinib for unresectable hepatocellular carcinoma in the new era of systemic chemotherapy-Reference-Cited by-同舟云学术

Prospect of lenvatinib for unresectable hepatocellular carcinoma in the new era of systemic chemotherapy

Published:2021-12-15 Issue:12 Volume:13 Page:2076-2087
ISSN:1948-5204
Container-title:World Journal of Gastrointestinal Oncology
language:
Short-container-title:WJGO

Author:

Sho Takuya,Morikawa Kenichi,Kubo Akinori,Tokuchi Yoshimasa,Kitagataya Takashi,Yamada Ren,Shigesawa Taku,Kimura Mugumi,Nakai Masato,Suda Goki,Natsuizaka Mitsuteru,Ogawa Koji,Sakamoto Naoya

Publisher

Baishideng Publishing Group Inc.

Subject

Gastroenterology,Oncology

Reference64 articles.

1. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries

2. Hepatocellular carcinoma

3. Prognosis of Hepatocellular Carcinoma: The BCLC Staging Classification

4. Sorafenib in Advanced Hepatocellular Carcinoma

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Case of Giant Hepatocellular Carcinoma Successfully Treated with Lenvatinib Followed by Parenchymal-Sparing Hepatectomy;The Japanese Journal of Gastroenterological Surgery;2023-10-01

2. Analysis of the safety and effectiveness of TACE combined with targeted immunotherapy in the treatment of intermediate and advanced hepatocellular carcinoma;Medical Oncology;2023-07-27

3. Five years of lenvatinib in hepatocellular carcinoma: are there any predictive and/or prognostic factors?;Expert Review of Anticancer Therapy;2022-12-14

4. Hepatocellular carcinoma cells loss lenvatinib efficacy in vitro through autophagy and hypoxia response-derived neuropilin-1 degradation;Acta Pharmacologica Sinica;2022-11-14